The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation—A Narrative Review
Nutrients · 06.09.2025 · 17 (17) · 2884
DOI: 10.3390/nu17172884 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 06.09.2025. Verfasst von Andrea Lehoczki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Preventive Medicine and Public Health, Semmelweis University, 1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Curcumin, Neuroprotective Agents, Neurodegenerative Diseases. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Cardiovascular Laboratory Program, National Research, Development and Innovation Fund.
Abstract (Originalsprache)
Neurodegenerative disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and post-stroke cognitive impairment (PSCI), represent an escalating global health and economic challenge. In the quest for disease-modifying interventions, natural polyphenols—most notably curcumin, the principal bioactive compound of Curcuma longa—have attracted considerable interest due to their pleiotropic neuroprotective effects. This narrative review critically synthesizes findings from a selection of peer-reviewed articles published between 2000 and 2025, chosen for their relevance to curcumin’s molecular mechanisms and translational potential. Curcumin’s complex chemical structure confers antioxidant, anti-inflammatory, and epigenetic modulatory properties; however, its clinical application is limited by poor oral bioavailability. Mechanistically, curcumin attenuates oxidative stress and suppresses key inflammatory mediators, including nuclear factor kappa B (NF-κB), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Additionally, it modulates apoptosis, inhibits amyloid-beta aggregation, and enhances cellular quality control processes such as autophagy and mitophagy, while upregulating neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Preclinical studies employing rodent models of AD, PD, and ischemic stroke have demonstrated curcumin’s dose-dependent neuroprotective efficacy, with improved outcomes observed using nanoparticle-based delivery systems. Early-phase clinical trials further support curcumin’s favorable safety profile and potential cognitive benefits, although challenges remain regarding pharmacokinetics, formulation standardization, and therapeutic reproducibility. Future directions include the development of advanced drug delivery platforms, combinatory therapeutic regimens, and personalized medicine approaches integrating curcumin within multifaceted neurotherapeutic strategies. Collectively, this narrative review highlights curcumin as a promising multi-targeted candidate for combating neurodegenerative diseases, while emphasizing the need for further translational and clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Preventive Medicine and Public Health, Semmelweis University, 1085 Budapest, Hungary.
- Fodor Center for Prevention and Healthy Aging, Semmelweis University, 1085 Budapest, Hungary.
- Health Sciences Division, Doctoral College, Semmelweis University, 1085 Budapest, Hungary.
- Department of Neurology and Stroke, Saint John's Central Hospital of North Buda, 1125 Budapest, Hungary.
- Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
- Department of Rheumatology and Clinical Immunology, Semmelweis University, 1085 Budapest, Hungary.
ORCID-Profile: Andrea Lehoczki, Mónika Fekete, Tamás Jarecsny, Ágnes Lipécz, Dávid Major, Vince Fazekas-Pongor, János Tamás Varga
Förderung
- NIA NIH HHS
- National Cardiovascular Laboratory Program
- National Research, Development and Innovation Fund
- Semmelweis University
- National Research, Development and Innovation Fund under TKP2021-NKTA
- Ministry of Innovation and Technology under the National Cardiovascular Laboratory Program
- European University for Well-Being (EUniWell) program
- National Institute on Aging
Zitieren
APA
Lehoczki, A., Fekete, M., Jarecsny, T., Zábó, V., Szappanos, Á., Csípő, T., Lipécz, Á., Major, D., Fazekas-Pongor, V., Varga, P., & Varga, J. T. (2025). The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation—A Narrative Review. Nutrients, 17(17), 2884. https://doi.org/10.3390/nu17172884
Vancouver
Lehoczki A, Fekete M, Jarecsny T, Zábó V, Szappanos Á, Csípő T, et al. The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation—A Narrative Review. Nutrients. 2025;17(17):2884. doi:10.3390/nu17172884
BibTeX
@article{Lehoczki2025,
author = {Lehoczki, Andrea and Fekete, Mónika and Jarecsny, Tamás and Zábó, Virág and Szappanos, Ágnes and Csípő, Tamás and Lipécz, Ágnes and Major, Dávid and Fazekas-Pongor, Vince and Varga, Péter and Varga, János Tamás},
title = {The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation—A Narrative Review},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {17},
pages = {2884},
doi = {10.3390/nu17172884}
}
EUVIMED